
Results
25
Most Popular Stocks on the market
25 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł20.90
7D
-1.9%
1Y
-16.4%
Selvita
Market Cap: zł826.0m
Operates as a contract research organization worldwide.
SLV
zł45.00
7D
-4.1%
1Y
-1.9%
Ryvu Therapeutics
Market Cap: zł601.1m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł26.00
7D
-5.5%
1Y
-12.0%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł445.6m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł80.60
7D
-1.7%
1Y
71.9%
Bioceltix
Market Cap: zł391.0m
Engages in the development of stem cell-based biopharmaceuticals for veterinary use.
BCX
zł79.40
7D
-3.9%
1Y
-5.1%
BIOTON
Market Cap: zł347.8m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.05
7D
-0.7%
1Y
13.6%
Synthaverse
Market Cap: zł284.5m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł4.02
7D
-3.4%
1Y
-7.2%
Molecure
Market Cap: zł148.8m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł7.22
7D
-1.1%
1Y
-27.6%
Mabion
Market Cap: zł130.8m
A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
MAB
zł8.09
7D
-4.8%
1Y
-14.7%
Poltreg
Market Cap: zł123.1m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł26.40
7D
-2.2%
1Y
-31.6%
NanoGroup
Market Cap: zł82.7m
Operates as a biotechnology company in Poland.
NNG
zł2.57
7D
-1.2%
1Y
-17.9%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
Urteste
Market Cap: zł65.8m
Engages in the research and development of diagnostic tests for cancers.
URT
zł46.70
7D
6.1%
1Y
-50.4%
Read-Gene
Market Cap: zł64.1m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł5.44
7D
-9.0%
1Y
18.3%
Genomtec
Market Cap: zł58.1m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł3.86
7D
1.4%
1Y
-47.6%
Biogened
Market Cap: zł52.1m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł21.20
7D
-1.9%
1Y
-18.5%
Genomed Spólka Akcyjna
Market Cap: zł39.6m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł30.00
7D
2.7%
1Y
7.9%
Pure Biologics
Market Cap: zł33.0m
A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.
PUR
zł4.04
7D
-2.6%
1Y
-75.0%
Medicofarma Biotech
Market Cap: zł30.3m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.45
7D
-7.3%
1Y
21.6%
Stem Cells Spin
Market Cap: zł15.1m
Operates as a biotechnology company in Poland.
SCS
zł0.37
7D
-9.9%
1Y
69.4%
genXone
Market Cap: zł13.9m
Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
GX1
zł4.20
7D
-1.6%
1Y
-34.4%
Green Zebras Spolka Akcyjna
Market Cap: zł12.2m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.20
7D
-3.2%
1Y
-33.3%
Cannabis Poland
Market Cap: zł9.6m
Operates in the medical cannabis industry in Poland.
CBD
zł0.19
7D
-8.0%
1Y
-42.8%
Labocanna
Market Cap: zł4.7m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.22
7D
1.8%
1Y
-34.1%
Vinci Gen
Market Cap: zł3.4m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
VGN
zł0.31
7D
4.7%
1Y
-33.2%